A prospective study of antibiotic prescribing in an emergency care unit;Évaluation de la qualité des prescriptions d'antibiotiques dans le service d'accueil des urgences d'un CHU en région parisienne

Medecine et Maladies Infectieuses

Volumn 39, Issue 1, 2009, Pages 48-54

  Goulet, H ^a   Daneluzzi, V ^a   Dupont, C ^a   Heym, B ^a   Page, B ^a   Almeida, K ^a   Auvert, B ^a   Elkharrat, D ^a   Rouveix, E ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Antibiotics; Clinical audit; Emergency unit

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; PRESCRIPTION DRUG;

ANTIBIOTIC THERAPY; CONTROLLED STUDY; DRUG CHOICE; DRUG QUALITY; EMERGENCY CARE; FEMALE; HEALTH BEHAVIOR; HEALTH CARE QUALITY; HUMAN; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; SKIN INFECTION; TRAINING; URINARY TRACT INFECTION; ARTICLE; BACTERIAL INFECTION; COMORBIDITY; EMERGENCY HEALTH SERVICE; HOSPITALIZATION; MIDDLE AGED; PROSPECTIVE STUDY; STATISTICS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COMORBIDITY; EMERGENCY MEDICAL SERVICES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PRESCRIPTION DRUGS; PROSPECTIVE STUDIES;

EID: 57949101657     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2008.09.022     Document Type: Review

References (45)

1. Goossens H., and Sprenger M.J. Community aquired infections and bacterial resistance. BMJ 317 (1998) 654-657
2. Gould I.M. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother 43 (1999) 459-465
3. Goossens H., Ferech M., Vander Stichele R., Elseviers M., and ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365 (2005) 548-549
4. Cars O., Mölstad S., and Melander A. Variation in antibiotic use in the European Union. Lancet 357 (2001) 1851-1853
5. Elseviers M.M., Ferech M., Vander Stichele R.H., Goossens H., and ESAC project group. Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf 16 (2007) 115-123
6. Hanberger H., Garcia-Rodriguez J.A., Gobernado M., Goossens H., Nilsson L.E., and Struelens M.J. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU study groups. JAMA 281 (1999) 67-71
7. EARSS. Annual report 2005.
8. Spellberg B., Powers J.H., Brass E.P., Miller L.G., and Edwards Jr. J.E. Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 38 (2004) 1279-1286
9. e conférence de consensus « Comment améliorer la qualité de l'antibiothérapie dans les établissements de soins ». Med Mal Infect 2002;32:320-8.
10. Holmberg S.D., Solomon S.L., and Blake P.A. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 9 (1987) 1065-1078
11. er octobre 2007.].
12. House of Lords. Select Committee on Science and Technology. Resistance to antibiotics and other antimicrobial agents. Session 1997-1998. Seventh Report. London: The stationery office, 1998.
13. Agence du médicament. Prescription et consommation des antibiotiques en ambulatoire. Presse Med 1999;28:343-50.
14. Avorn J., Harvey K., Soumerai S.B., Herxheimer A., Plumridge R., and Bardelay G. Information and education as determinants of antibiotic use: report of Task Force 5. Rev Infect Dis 9 Suppl. 3 (1987) S286-S296
15. Agence nationale pour le développement de l'évaluation médicale. Le bon usage des antibiotiques à l'hôpital : recommandations pour maîtriser le développement de la résistance bactérienne. NHA communication; 1997.
16. Ministère de la Santé. Plan national pour préserver l'efficacité des antibiotiques. http://www.sante.gouv.fr/htm/actu/antibio/sommaire.htm, [consulté le 20 septembre 2007].
17. o 2002-272 du 2 mai 2002 relative au bon usage des antibiotiques dans les établissements de santé et à la mise en place à titre expérimental de centres de conseil en antibiothérapie pour les médecins libéraux.
18. COMAI du CHU Ambroise-Paré. Évaluation de la qualité des prescriptions d'amoxicilline-acide clavulanique dans 5 services de médecine du CHU Ambroise-Paré. 2004.
19. e conférence de consensus. Prise en charge des plaies aux urgences. 2005.
20. Clements H., Stephenson T., Gabriel V., Harrison T., Millar M., Smyth A., et al. Rationalised prescribing for community acquired pneumonia: a closed loop audit. Arch Dis Child 83 (2000) 320-324
21. South M., Royle J., and Starr M. A simple intervention to improve hospital antibiotic prescribing. Med J Aust 178 (2003) 207-209
22. Roger P.M., Farhad R., Pulcini C., Mariette A., Taurel M., Oualid H., et al. Patients âgés fébriles avec signes respiratoires dans un service d'urgences. Impact diagnostique, thérapeutique et pronostique d'une consultation systématique d'infectiologie. Presse Med 32 (2003) 1699-1704
23. Naughton B.J., Mylotte J.M., Ramadan F., Karuza J., and Priore R.L. Antibiotic use, hospital admissions, and mortality before and after implementing guidelines for nursing home-acquired pneumonia. J Am Geriatr Soc 49 (2001) 1020-1024
24. e RICAI 1999;308:P2.
25. Faure C, Floret N, Patry I, Henon T, Talon D, Hoen B. Bon usage des fluoroquinolones en Franche-Comté : résultat d'un audit de pratiques. Med Mal Infect 2007;37(Suppl. 1):S102 (Abstract F-14).
26. Ledru S., Beliart D., François C., Clais J., Amourette J., and Canonne J.P. The interest and assessment of the application of antibiotic protocols in a department of pneumology. Presse Med 32 (2003) 1397-1402
27. Dean N.C., Silver M.P., Bateman K.A., James B., Hadlock C.J., and Hale D. Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. Am J Med 110 (2001) 451-457
28. Natsch S., Kullberg B.J., van der Meer J.W., and Meis J.F. Delay in administering the first dose of antibiotics in patients admitted to hospital with serious infections. Eur J Clin Microbiol Infect Dis 17 (1998) 681-684
29. Mortensen E.M., Restrepo M., Anzueto A., and Pugh J. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med 117 (2004) 726-731
30. Roger P.M., Martin C., Taurel M., Fournier J.P., Nicole I., Carles M., et al. Motives for the prescription of antibiotics in the emergency department of the University Hospital Center in Nice. A prospective study. Presse Med 31 (2002) 58-63
31. Lutters M., Harbarth S., Janssens J.P., Freudiger H., Herrmann F., Michel J.P., et al. Effect of a comprehensive, multidisciplinary, educational program on the use of antibiotics in a geriatric university hospital. J Am Geriatr Soc 52 (2004) 112-116
32. Schouten J.A., Hulscher M.E., Natsch S., Kullberg B.J., van der Meer J.W., and Grol R.P. Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study. Qual Saf Health Care 16 (2007) 143-149
33. Peetermans W.E. Prophylactic, empiric and therapeutic use of antibiotics. Do we need a guide: a universal edition or a local one?. Eur J Emerg Med 4 (1997) 15-18
34. Faryna A., Wergowske G.L., and Goldenberg K. Impact of therapeutic guidelines on antibiotic use by residents in primary care clinics. J Gen Intern Med 2 (1987) 102-107
35. Davis D.A., Thomson M.A., Oxman A.D., and Haynes R.B. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 274 (1995) 700-705
36. Onion C.W., and Bartzokas C.A. Changing attitudes to infection management in primary care: a controlled trial of active versus passive guideline implementation strategies. Fam Pract 15 (1998) 99-104
37. Solomon D.H., Van Houten L., Glynn R.J., Baden L., Curtis K., Schrager H., et al. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med 161 (2001) 1897-1902
38. David-Ouaknine F., Kinoo J., Echard Y., Hacquard B., and Decazes J.-M. Évaluation sur trois mois des prescriptions d'antibiothérapies systématiques à visée curative dans un centre hospitalier general de 759 lits. Med Mal Infect 29 (1999) 499-507
39. David-Ouaknine F., Kinoo J., Echard Y., Hacquard B., and Decazes J.-M. Impact de recommandations sur la pertinence des prescriptions d'antibiotiques. Med Mal Infect 33 (2003) 192-201
40. Causse R., Chouaid C., Callaert S., Le Paih M.F., Cohen R., and Thebault A. Impact of a multidisciplinary approach for monitoring prescribing of antibiotics in a hospital. Presse Med 27 (1998) 1371-1375
41. Mangione-Smith R., Elliott M.N., McDonald L., and McGlynn E.A. An observational study of antibiotic prescribing behavior and the Hawthorne effect. Health Serv Res 37 (2002) 1603-1623
42. Avorn J., and Solomon D.H. Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics. Ann Intern Med 133 (2000) 128-135
43. Zahar J.R., Ghaffari P., Kamga I., and Perronne V. Audit des prescriptions antibiotiques dans un service de maladies infectieuses. Enquête prospective observationnelle. Presse Med 32 (2003) 1208-1212
44. Byl B., Clevenbergh P., Jacobs F., Struelens M.J., Zech F., Kentos A., et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 29 (1999) 60-66 (discussion p. 67-8)
45. Roger P.M., Hyvernat H., Verleine-Pugliese S., Bourroul C., Giordano J., Fosse T., et al. Systematic infection consultation in the intensive care unit. Impact of short-term antibiotic use. Presse Med 29 (2000) 1640-1644